Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: Analysis of combined data from two phase III randomized clinical trials

Richard J. Gralla, Ronald De Wit, Jorn Herrstedt, Alexandra D. Carides, Juliana Ianus, Julie Guoguang-Ma, Judith K. Evans, Kevin J. Morgan

Research output: Contribution to journal › Article › peer-review

91 Scopus citations

Fingerprint

Dive into the research topics of 'Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: Analysis of combined data from two phase III randomized clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences